ENTRY       K14381                      KO
NAME        SQSTM1
DEFINITION  sequestosome 1
PATHWAY     ko04380  Osteoclast differentiation
DISEASE     H00437  Paget's disease of bone and related disorders
BRITE       KEGG Orthology (KO) [BR:ko00001]
             Organismal Systems
              Development
               04380 Osteoclast differentiation
                K14381  SQSTM1; sequestosome 1
            Mitochondrial biogenesis [BR:ko03029]
             Mitochondrial quality control factors
              Mitophagy factors
               Parkin-dependent mechanism factors
                K14381  SQSTM1; sequestosome 1
            Exosome [BR:ko04147]
             Exosomal proteins
              Exosomal proteins of other body fluids (saliva and urine)
               K14381  SQSTM1; sequestosome 1
GENES       HSA: 8878(SQSTM1)
            PTR: 462333(SQSTM1)
            PPS: 100981358(SQSTM1)
            GGO: 101147113(SQSTM1)
            PON: 100172461(SQSTM1)
            MCC: 705481(SQSTM1)
            MCF: 102144942(SQSTM1)
            MMU: 18412(Sqstm1)
            RNO: 113894(Sqstm1)
            CGE: 100768352(Sqstm1)
            HGL: 101724587(Sqstm1)
            TUP: 102498598(SQSTM1)
            CFA: 481459(SQSTM1)
            AML: 100469252
            FCA: 101085431(SQSTM1)
            PTG: 102964239(SQSTM1)
            BTA: 338045(SQSTM1)
            BOM: 102279447(SQSTM1)
            PHD: 102321969(SQSTM1)
            CHX: 102172251(SQSTM1)
            SSC: 100518718(SQSTM1)
            CFR: 102519914(SQSTM1)
            BACU: 103009745(SQSTM1)
            LVE: 103086579(SQSTM1)
            ECB: 100067231(SQSTM1)
            MYB: 102258898(SQSTM1)
            MYD: 102770732(SQSTM1)
            PALE: 102891735(SQSTM1)
            MDO: 100032104(SQSTM1)
            SHR: 100924705(SQSTM1)
            OAA: 100074478(SQSTM1)
            GGA: 770805(SQSTM1)
            MGP: 100543577
            TGU: 100218731 100222311(SQSTM1)
            FAB: 101807092(SQSTM1)
            PHI: 102110080(SQSTM1)
            APLA: 101790932(SQSTM1)
            FPG: 101919269(SQSTM1)
            FCH: 102053934(SQSTM1)
            CLV: 102097516(SQSTM1)
            ASN: 102373404(SQSTM1)
            AMJ: 102571004(SQSTM1)
            PSS: 102457855(SQSTM1)
            CMY: 102936852(SQSTM1)
            ACS: 100556955
            PBI: 103067573(SQSTM1)
            XLA: 379610(sqstm1)
            XTR: 493277(sqstm1)
            DRE: 406452(sqstm1)
            TRU: 101074386
            MZE: 101468330
            OLA: 101166287
            XMA: 102235769
            LCM: 102359142(SQSTM1)
            CMK: 103188227(sqstm1)
            BFO: BRAFLDRAFT_117230
            CIN: 100176775
            SPU: 590854
            AME: 408686(ref(2)P)
            NVI: 100124264
            BMOR: 101736823
            PHU: Phum_PHUM372150
            ISC: IscW_ISCW015997
            BMY: Bm1_50690
            LOA: LOAG_01401
            NVE: NEMVE_v1g239529
            HMG: 100211305
            TAD: TRIADDRAFT_64162
            AQU: 100631967 100637508
REFERENCE   PMID:16877352
  AUTHORS   Yip KH, Feng H, Pavlos NJ, Zheng MH, Xu J
  TITLE     p62 ubiquitin binding-associated domain mediated the receptor activator of nuclear factor-kappaB ligand-induced osteoclast formation: a new insight into the pathogenesis of Paget's disease of bone.
  JOURNAL   Am J Pathol 169:503-14 (2006)
REFERENCE   PMID:18382763
  AUTHORS   Jin W, Chang M, Paul EM, Babu G, Lee AJ, Reiley W, Wright A, Zhang M, You J, Sun SC
  TITLE     Deubiquitinating enzyme CYLD negatively regulates RANK signaling and osteoclastogenesis in mice.
  JOURNAL   J Clin Invest 118:1858-66 (2008)
///
